Tetra Tech

Business

Baidu's Stock Surge: A 75% Annual Gain Defies Earnings Slump, Spotlighting AI Ambitions

While passive index funds track the broader market, selective stock picks can deliver outsized returns. Baidu's (NASDAQ: BIDU) shares have soared 75% in the past year, dramatically outpacing the market. This rally comes despite a significant drop in earnings, shifting investor focus towards the company's long-term strategic bets in artificial intelligence and autonomous driving.

Feb 2, 2026

Business

Amid Crypto Rout, Hyperliquid's HYPE Token Defies Downturn as Traders Seek Shelter

As Bitcoin and major altcoins extend losses, the native token of decentralized exchange Hyperliquid has surged over 40% in a week, with its novel permissionless markets hitting record volumes, prompting some to label it a rare 'defensive' crypto asset.

Feb 2, 2026

Business

Bitcoin Finds Footing as Weekday Traders Step In Following Steep Weekend Sell-Off

Bitcoin staged a tentative recovery Monday, clawing back some losses after a volatile weekend saw prices plunge 11%. Analysts point to the return of institutional and ETF activity, though broader market headwinds from geopolitics to potential Fed policy shifts continue to cloud the outlook.

Feb 2, 2026

Business

Nevada Court Halts Polymarket Operations, Spotlighting Legal Peril for U.S. Prediction Markets

A Nevada court has issued a temporary restraining order against prediction market platform Polymarket, barring it from offering event-based betting to state residents. The ruling intensifies the regulatory clash between state gambling laws and federal financial frameworks, casting uncertainty over the future of crypto-powered prediction markets in the U.S.

Feb 2, 2026

Business

GSK Returns Rights to Wave's Pioneering RNA Editing Therapy, Citing Strategic Focus Shift

In a strategic reversal, GSK has handed back global rights to the clinical-stage RNA editing drug WVE-006 to Wave Life Sciences. Wave asserts the move allows it to faster advance the potential 'functional cure' for alpha-1 antitrypsin deficiency, while GSK refocuses on broader respiratory markets.

Feb 2, 2026

World

Sicilian Town of Niscemi Teeters on the Brink as Landslide Exposes Decades of Neglect

A catastrophic landslide has torn through the historic Sicilian town of Niscemi, forcing mass evacuations and exposing a legacy of bureaucratic delays and unheeded geological warnings that left the community perilously vulnerable.

Feb 2, 2026

Business

AI Model Projects Modest Dip for JPMorgan Shares Over Next Two Months Amid Cost, Regulatory Pressures

An AI-driven analysis suggests JPMorgan Chase stock could see a slight decline to around $295 by mid-April, as the banking giant contends with rising operational costs and regulatory uncertainty, despite strong fundamentals and shareholder returns.

Feb 2, 2026

Business

Curreen Capital's 'Crazy Cheap' Bet on Fortrea Pays Off as Fund Posts Strong 2025 Gains

Investment firm Curreen Capital, known for targeting undervalued 'ugly duckling' companies, highlighted contract research organization Fortrea Holdings as a prime example of its strategy in its latest investor letter. The firm reported a 30.97% return for 2025.

Feb 2, 2026

Business

Nvidia's AI Dominance and the $3 Trillion Data Center Boom: Why Analysts See Room to Run

As the AI infrastructure race accelerates, Nvidia's relentless innovation cycle and commanding market position point to sustained growth, with data center spending projected to reach trillions annually by 2030.

Feb 2, 2026

Business

Polish E-Commerce Battle Escalates: Erli Files Antitrust Lawsuit Against Allegro Over Pricing Practices

Polish online marketplace Erli has filed a lawsuit against dominant rival Allegro, alleging the platform abuses its market power to pressure sellers into maintaining higher prices on competing sites. Allegro denies the accusations, stating its seller benefit programs are voluntary.

Feb 2, 2026

Business

Crypto Mogul Justin Sun Plans $100M Bitcoin Buy Amid Market Downturn

Tron founder Justin Sun announces plans to acquire up to $100 million in Bitcoin as prices dip below $77,000, contrasting with corporate treasury losses and broader market caution.

Feb 2, 2026

Business

Crypto Funds Bleed $1.7 Billion in a Week as ETF Enthusiasm Cools

Digital asset investment products faced massive withdrawals last week, with U.S. spot Bitcoin ETFs leading the sell-off. The outflows have pushed year-to-date net redemptions past $1 billion, signaling a sharp shift in investor sentiment amid market turmoil.

Feb 2, 2026

Business

Blockstream CEO Adam Back Denies Epstein Ties as New Documents Fuel Crypto Community Backlash

Newly unsealed court records from the Jeffrey Epstein case have ensnared Bitcoin pioneer Adam Back, CEO of Blockstream, revealing past connections that sparked fierce criticism despite his firm denial of any ongoing relationship with the disgraced financier.

Feb 2, 2026

Business

Nvidia's Strategic Expansion: A $2 Billion CoreWeave Investment Highlights Broader AI Portfolio Strategy

Nvidia continues its aggressive investment strategy with a major stake in cloud provider CoreWeave, signaling a calculated approach to consolidating its AI ecosystem amid market volatility and shifting valuations.

Feb 2, 2026

Business

Ripple Secures Key EU License in Luxembourg, Bolstering European Expansion

Ripple Labs has obtained a full Electronic Money Institution (EMI) license from Luxembourg's financial regulator, marking a significant step in its European regulatory strategy and enabling the expansion of its payment services across the EU single market.

Feb 2, 2026

Business

CrossCurve Thwarts Multi-Million Dollar Bridge Exploit, Demands Hacker's Surrender

The CrossCurve DeFi protocol has contained a bridge attack exploiting a smart contract flaw, preventing the circulation of stolen tokens. As January's crypto thefts surge to an 11-month high, the team issues a 72-hour ultimatum for the return of funds.

Feb 2, 2026

Business

Pfizer's Pandemic Gambit: How Moral Clarity Fueled a Vaccine Production Miracle

Faced with scaling annual vaccine output from 200 million to 3 billion doses, CEO Albert Bourla reframed an operational nightmare as a moral imperative, unlocking what he calls "miracles" of human effort.

Feb 2, 2026

Business

AMD's Steady Execution Charts a Course for Long-Term Growth, Says Ashva Capital

Investment firm Ashva Capital Management highlights Advanced Micro Devices (AMD) in its latest investor letter, citing the chipmaker's disciplined execution as a cornerstone for enduring growth, even as the fund's overall 2025 returns trailed major indices.

Feb 2, 2026

Business

Epstein Files Reveal Early Crypto Rivalry: 2014 Email Shows Bitcoin Insiders Saw Ripple as Strategic Threat

A newly surfaced 2014 email from the Jeffrey Epstein documents reveals Bitcoin-aligned executives warning investors about backing rival projects like Ripple. Some XRP proponents are framing the disclosure as validation of the token's early significance, though market momentum remains bearish.

Feb 2, 2026

Business

EQB's Five-Year Surge: How a 117% Total Return Outpaced the TSX

Shares of Canadian challenger bank EQB have delivered stellar long-term gains, significantly outperforming the broader market. While recent momentum has cooled, the stock's journey offers insights into the power of dividends and shifting market sentiment.

Feb 2, 2026